[Skip to Content]
[Skip to Content Landing]
Editorial
November 2, 2005

Cervical Cancer PreventionMaking Programs More Appropriate and Pragmatic

Author Affiliations
 

Author Affiliations: Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Md (Dr Blumenthal); and Evaluation and Research Technologies for Health Inc, Oakland, Calif (Dr Gaffikin).

JAMA. 2005;294(17):2225-2228. doi:10.1001/jama.294.17.2225

Cervical cancer is unique for several reasons. It has recognized, well-described risk factors; there is an identifiable precancerous condition; the transition from precancer to cancer occurs over an extended period (10 years on average)1; screening tests for detecting cancer and precancer exist; and outpatient treatments for precancer are safe, effective, and relatively inexpensive.

First Page Preview View Large
First page PDF preview
First page PDF preview
×